Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Thrombosis and Haemostasis
DOI: 10.1160/th11-04-0216
Institutions: Karolinska University Hospital, Karolinska Institutet
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: aspirin, twice-daily dosing, type 2 diabetes, platelet aggregation inhibition, platelet turnover, reticulated platelets, mean platelet volume, urinary 11-dehydrothromboxane B2, microvascular complications, macrovascular complications, arachidonic acid-induced platelet aggregation, collagen-induced aggregation, high-dose aspirin
Open Access status: closed
OpenAlex ID: W2054008451
